S

Satnarayan

Active Director Designated Partner DIN 10826175
DIN 10826175 First appointment Nov 2024 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2024
Shareholding value Locked Premium profile

About Satnarayan

Satnarayan has 1 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Kirti Pharmaceuticals Llp. Engaged in General Business. Contributes to corporate operations.

DIN 10826175
Primary Designation Designated Partner
First Appointment 01 Nov 2024
Oldest Company Age 1 yrs

Current companies

Company Designation Appointment Founded Status
Designated Partner 01 Nov 2024 2024 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kirti Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Satnarayan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satnarayan

Satnarayan has 1 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Kirti Pharmaceuticals Llp. Engaged in General Business. Contributes to corporate operations.

Satnarayan is associated with 1 company as Designated Partner.

Satnarayan has expertise in General Business.

Satnarayan has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available